DNA and Gene Cloning Services Market Size, Scope, Forecast Report 2026 to 2035
Segmentation Of DNA and Gene Cloning Services Market
Global DNA and Gene Cloning Services Market, by Type of Service Offered
- Custom Cloning
- Gene Synthesis
- Sub-cloning
- Others
Global DNA and Gene Cloning Services Market, by Type of Company Size
- Small
- Medium
- Large
Global DNA and Gene Cloning Services Market, by Type of Gene
- Complex Gene
- Standard Gene
- Others
Global DNA and Gene Cloning Services Market, by End-User Industry
- Academic and R&D
- Pharmaceutical and Biotechnology Companies
- Others
Global DNA and Gene Cloning Services Market, by Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global DNA and Gene Cloning Services Market Snapshot
Chapter 4. Global DNA and Gene Cloning Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type of Service Offered Estimates & Trend Analysis
5.1. By Type of Service Offered & Market Share, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Type of Service Offered:
5.2.1. Custom Cloning
5.2.2. Gene Synthesis
5.2.3. Sub-cloning
5.2.4. Others
Chapter 6. Market Segmentation 1: By Type of Company Size Estimates & Trend Analysis
6.1. By Type of Company Size & Market Share, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Type of Company Size:
6.2.1. Small
6.2.2. Medium
6.2.3. Large
Chapter 7. Market Segmentation 2: By Type of Gene Estimates & Trend Analysis
7.1. By Type of Gene & Market Share, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Type of Gene:
7.2.1. Complex Gene
7.2.2. Standard Gene
7.2.3. Others
Chapter 8. Market Segmentation 3: By End-user Estimates & Trend Analysis
8.1. By End-user & Market Share, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By End-user:
8.2.1. Academic and R&D
8.2.2. Pharmaceutical and Biotechnology Companies
8.2.3. Others
Chapter 9. DNA and Gene Cloning Services Market Segmentation 4: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts By Type of Service Offered, 2022 - 2035
9.1.2. North America DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts By Type of Company Size, 2022 - 2035
9.1.2. North America DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts By Type of Gene, 2022 - 2035
9.1.3. North America DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts by End-user, 2022 - 2035
9.1.4. North America DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2035
9.2. Europe
9.2.1. Europe DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Service Offered, 2022 - 2035
9.2.2. Europe DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Company Size, 2022 - 2035
9.2.2. Europe DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Gene, 2022 - 2035
9.2.3. Europe DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts by End-user, 2022 - 2035
9.2.4. Europe DNA and Gene Cloning Services Market revenue (US$ Million) by country, 2022 - 2035
9.3. Asia Pacific
9.3.1. Asia Pacific DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Service Offered, 2022 - 2035
9.3.2. Asia Pacific DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Company Size, 2022 - 2035
9.3.3. Asia Pacific DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts by End-user, 2022 - 2035
9.3.4. Asia Pacific DNA and Gene Cloning Services Market revenue (US$ Million) by country, 2022 - 2035
9.4. Latin America
9.4.1. Latin America DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Service Offered, (US$ Million) 2022 - 2035
9.4.2. Latin America DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Company Size, (US$ Million) 2022 - 2035
9.4.2. Latin America DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Gene, (US$ Million) 2022 - 2035
9.4.3. Latin America DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts by End-user, 2022 - 2035
9.4.4. Latin America DNA and Gene Cloning Services Market revenue (US$ Million) by country, 2022 - 2035
9.5. Middle East & Africa
9.5.1. Middle East & Africa DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Service Offered, (US$ Million) 2022 - 2035
9.5.2. Middle East & Africa DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Company Size, (US$ Million) 2022 - 2035
9.5.2. Middle East & Africa DNA and Gene Cloning Services Market revenue (US$ Million) By Type of Gene, (US$ Million) 2022 - 2035
9.5.3. Middle East & Africa DNA and Gene Cloning Services Market revenue (US$ Million) estimates and forecasts by End-user, 2022 - 2035
9.5.4. Middle East & Africa DNA and Gene Cloning Services Market revenue (US$ Million) by country, 2022 - 2035
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Bio-Techne
10.2.2. Charles River Laboratories
10.2.3. Curia
10.2.4. Eurofins
10.2.5. GenScript
10.2.6. Integrated DNA Technologies
10.2.7. MedGenome
10.2.8. Sino Biological
10.2.9. Syngene
10.2.10. Twist Bioscience
10.2.11. Thermo Fisher Scientific Inc.
10.2.12. Eurofins Scientific
10.2.13. GenScript
10.2.14. Merck KGaA
10.2.15. Takara Bio Inc.
10.2.16. Lonza
10.2.17. Sartorius AG
10.2.18. Creative Biogene
10.2.19. Cellecta, Inc.
10.2.20. Synbio Technologies
10.2.21. TransGen Biotech Co., Ltd.
10.2.22. Dobuss (Canvax)
10.2.23. Azenta US, Inc.
10.2.24. Macrogen, Inc.
10.2.25. Codex DNA, Inc.
10.2.26. Bio-Rad
10.2.27. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
DNA and Gene Cloning Services Market is expected to grow at a 17.0% CAGR during the forecast period for 2026-2035.
Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Others
DNA and Gene Cloning Services Market Size is valued at USD 3.68 Bn in 2025 and is predicted to reach USD 17.49 Bn by the year 2035.
DNA and Gene Cloning Services market is segmented into three main aspects, the type of services offered, which comprises Custom cloning, gene synthesis, sub-cloning and others.
North America region is leading the DNA and Gene Cloning Services Market.